| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/07/1996 | EP0695352A1 Dna encoding cobra c3, cvf1, and cvf2 |
| 02/07/1996 | EP0695189A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 02/06/1996 | CA1338032C Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas |
| 02/05/1996 | CA2155397A1 Novel mutant br96 antibodies and functional equivalents reactive with human carcinomas |
| 02/01/1996 | WO1996002648A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 02/01/1996 | WO1996002645A2 Htk ligand |
| 02/01/1996 | WO1996002575A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same |
| 02/01/1996 | WO1996002574A1 Process for modifying the stability of antibodies |
| 02/01/1996 | WO1996002561A1 Interaction trap systems for detecting protein interactions |
| 02/01/1996 | CA2194955A1 Htk ligand |
| 02/01/1996 | CA2194784A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same |
| 01/30/1996 | US5488036 Gonadotrophins in cells for polypeptide hormones |
| 01/25/1996 | WO1996002000A1 E6 binding proteins |
| 01/25/1996 | WO1996001839A1 Novel cytokine designated lerk-5 |
| 01/25/1996 | WO1996001653A1 Methods and compositions for the specific coagulation of vasculature |
| 01/25/1996 | WO1996001650A1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 01/25/1996 | CA2194299A1 Novel cytokine designated lerk-5 |
| 01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |
| 01/23/1996 | US5486463 TNF-muteins |
| 01/18/1996 | WO1996001429A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/18/1996 | WO1996001316A1 NOVEL GROWTH OR DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 01/18/1996 | WO1996001313A1 Tetracycline-regulated transcriptional modulators |
| 01/18/1996 | WO1995034320A3 Methods for inhibiting antigen specific t cell responses |
| 01/18/1996 | DE4425115A1 Verfahren zur Modifizierung der Stabilität von Antikörpern A method for modifying the stability of antibodies |
| 01/18/1996 | CA2192565A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/17/1996 | EP0692537A2 Recombinant gibberellin DNA and uses thereof |
| 01/17/1996 | EP0692029A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 01/17/1996 | EP0691989A1 Biologically active polypeptide fusion dimers |
| 01/16/1996 | US5484891 Pure polypeptide able to hybridize under low stringency conditions; glycoproteins |
| 01/16/1996 | US5484591 Method for treating gram negative bacterial infections in humans |
| 01/11/1996 | WO1996000783A1 Antibodies which bind to insect gut proteins and their use |
| 01/11/1996 | DE4423392A1 Verfahren zur Identifizierung antigener Peptide A method for identifying antigenic peptides |
| 01/11/1996 | DE19515310A1 Artificial hip ball joint |
| 01/11/1996 | CA2193859A1 Antibodies which bind to insect gut proteins and their use |
| 01/09/1996 | US5482708 Leukemia, proteins are not adjacent in native protein |
| 01/04/1996 | WO1996000289A1 Protocadherin proteins and their uses |
| 01/04/1996 | CA2170156A1 Protocadherin proteins and their uses |
| 01/03/1996 | EP0690071A2 Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
| 01/03/1996 | EP0689600A1 Process to induce the death of tumor cells |
| 01/03/1996 | EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/03/1996 | EP0689551A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/03/1996 | EP0473701B1 Recombinant dna method for production of parathyroid hormone |
| 01/03/1996 | EP0316440B1 System and method for providing localized Mössbauer absorption in an organic medium |
| 01/02/1996 | US5480966 Peptides derived from the envelope glycoprotein of HIV viruses, their applications to the detection of infection caused by these viruses and to the vaccination against AIDS |
| 01/02/1996 | CA2150532A1 Polypeptides |
| 12/28/1995 | WO1995020664A3 Mammalian expression systems for hepatitis c virus envelope genes |
| 12/27/1995 | EP0688868A1 Genetic detoxification of pertussis toxin |
| 12/27/1995 | EP0688316A1 Coupling method using selective amination of maleimide |
| 12/26/1995 | CA1337801C Immobilized artificial membranes |
| 12/21/1995 | WO1995034648A1 A method for displaying proteins |
| 12/21/1995 | WO1995034320A2 Methods for inhibiting antigen specific t cell responses |
| 12/21/1995 | WO1995030750A3 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 12/21/1995 | CA2192662A1 Method of detecting compounds utilizing genetically modified lambdoid bacteriophage |
| 12/21/1995 | CA2191733A1 Methods for inhibiting antigen specific t cell responses |
| 12/21/1995 | CA2169358A1 A method for displaying proteins |
| 12/20/1995 | EP0687183A1 Synergistic composition of cd4-based protein and anti-hiv-1 antibody, and methods of using same |
| 12/20/1995 | EP0669933A4 PURIFICATION OF FUSION PROTEINS COMPRISING GM-CSF and IL-3. |
| 12/19/1995 | US5476786 Host cell harboring and capable of expressing DNA encoding single chain recombinant polypeptide having site for binding preselected antigen |
| 12/19/1995 | US5476781 Genetic engineering |
| 12/19/1995 | CA1337755C Monoclonal antibodies for human non-small cell lung carcinomas |
| 12/18/1995 | CA2151627A1 Recombinant gibberellin dna and uses thereof |
| 12/14/1995 | WO1995033481A1 Diphtheria toxin vaccines bearing a mutated r domain |
| 12/14/1995 | CA2191239A1 Diphtheria toxin vaccines bearing a mutated r domain |
| 12/13/1995 | EP0686161A1 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT |
| 12/12/1995 | US5475100 An antibody having antigen binding activity and which has a heavy chain constant region into which has been inserted arganine-glycine-aspartic acid and serine amino acid sequence, giving antibody affinity for cells |
| 12/12/1995 | US5474914 Method of producing secreted CMV glycoprotein H |
| 12/07/1995 | WO1995033057A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
| 12/07/1995 | CA2191306A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
| 12/06/1995 | EP0684997A1 Anthrax toxin fusion proteins and uses thereof |
| 12/06/1995 | EP0684956A1 Acylated protein aggregates and their use in enhancing signals in an immunoassay testing for antibodies |
| 12/06/1995 | EP0684841A1 Protein conjugates, compositions containing them and their applications as medicament |
| 12/06/1995 | EP0429542B1 Leukocyte adhesion inhibitor |
| 12/05/1995 | US5473049 Process for obtaining proinsulin possessing correctly linked cystine bridges |
| 12/05/1995 | US5472939 Method of treating complement mediated disorders |
| 11/29/1995 | EP0460076B1 Genetically engineered immunoglobulins |
| 11/29/1995 | EP0412116B1 Detection of neu gene expression and products |
| 11/29/1995 | CN1112795A A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes GP 130 |
| 11/28/1995 | US5470953 Human β2 integrin α subunit |
| 11/28/1995 | US5470734 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 11/28/1995 | US5470573 Immunogens comprising the non-lytic membrane spanning domain of bacteriophages MS2 or PhiX174 |
| 11/28/1995 | CA1337641C Recombinant dna product and method |
| 11/28/1995 | CA1337640C Recombinant dna product and method |
| 11/23/1995 | WO1995031556A1 Glucan-binding proteins, and use thereof |
| 11/23/1995 | WO1995031555A1 Fusion glycoprotein from hcmv and hsv |
| 11/23/1995 | WO1995031540A1 Trimerising polypeptides, their manufacture and use |
| 11/23/1995 | WO1995031483A1 Improvements in or relating to peptide delivery |
| 11/23/1995 | WO1995031472A1 Chimeric mhc class i antigens for inducing allograft tolerance |
| 11/23/1995 | WO1995031429A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 11/23/1995 | CA2490080A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
| 11/23/1995 | CA2372569A1 Heterodimer polypeptide immunogen carrier composition and method |
| 11/23/1995 | CA2190576A1 Chimeric mhc class i antigens for inducing allograft tolerance |
| 11/23/1995 | CA2190529A1 Fusion glycoprotein from hcmv and hsv |
| 11/23/1995 | CA2190264A1 Trimerising polypeptides, their manufacture and use |
| 11/23/1995 | CA2190101A1 Improvements in or relating to peptide delivery |
| 11/22/1995 | EP0682710A1 Immobilized proteins with specific binding capacities and their use in processes and products |
| 11/18/1995 | CA2148724A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica |
| 11/16/1995 | WO1995030750A2 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 11/16/1995 | WO1995019371A3 Expression of surface layer proteins |
| 11/15/1995 | EP0682114A2 Expression of recombinant MPF-4, CPF-4, PF-4 and precursor compounds |
| 11/15/1995 | EP0682040A1 Humanized immunoglobulins and their production and use |